Latest News Archive

Please select Category, Year, and then Month to display items

Kovsie ACT presents seventh Eco-Vehicle Race

24 April 2024 | Story Leonie Bolleurs | Photo Supplied

Eco-vehicles race — Join the UFS on 18 May 2024 from 10:00-13:00 at the Red Square Parking area for the seventh annual Kovsie ACT Eco-Vehicle Race. Come and support your favourite team to victory!

Kovsie ACT at the University of the Free State (UFS) proudly presents the seventh Kovsie Eco-Vehicle Race, set to take place at the Equitas Parking area on the Bloemfontein Campus.

According to Karen Scheepers, Assistant Director: Student Life, ten teams will be participating in this year’s race, featuring the three UFS campuses as well as the Central University of Technology. The event promise excitement like never before.

Scheepers says, besides an exciting race, spectators can look forward to a new track and viewing area. She invites the public, staff and students to come and support the competing teams as they showcase their skills on the racetrack.

Event details:

Date: Saturday 18 May 2024
Time: 10:00-13:00
Venue: Red Square Parking area (opposite George du Toit Building)

Click here to Livestream

Breakdown of the programme:

09:00 -10:15 Performance by student artists

10:15 -10:35 Walkthrough by judges

10:35 -10:40 Welcoming

10:40 Races commence

12:30 -13:00 Announcement of winners

13:00 -14:00 Performance by student artists

The Eco-Vehicle Race marks the culmination of a nine-month co-curricular skills programme, aimed at empowering participating students with a set of skills for the world of work. Through this programme, they are equipped with basic knowledge and abilities on sustainable energy, enabling them not only to compete in the eco-vehicle race but also to comprehend the inner workings of the vehicle. This understanding is important to the teams for when they are doing repairs during the race.

Students will be competing in three events:

• Obstacle course: Teams will be challenged by obstacles to test their control over the car.

• Smart lap: A timed lap in which the drivers take the main track for the first time.

• Endurance race: The teams need to finish as many laps as possible using the least amount of energy in 45 minutes.

The winners of the three events will each be awarded a trophy. Additionally, there will be a trophy for the best pit stop as well as a spirit cup for the team with the best energy and support from the audience.

For more information, contact Teddy Sibiya.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept